These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 23047817)

  • 1. Aortic augmentation index is independently associated with N-terminal pro B-type natriuretic peptide in patients with peripheral arterial disease.
    Shahin Y; Chetter I
    Vasc Endovascular Surg; 2012 Nov; 46(8):648-53. PubMed ID: 23047817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
    Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic augmentation index in patients with peripheral arterial disease.
    Catalano M; Scandale G; Carzaniga G; Cinquini M; Minola M; Antoniazzi V; Dimitrov G; Carotta M
    J Clin Hypertens (Greenwich); 2014 Nov; 16(11):782-7. PubMed ID: 25228305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.
    Kals J; Zagura M; Serg M; Kampus P; Zilmer K; Unt E; Lieberg J; Eha J; Peetsalu A; Zilmer M
    Scand J Clin Lab Invest; 2011 Jul; 71(4):257-63. PubMed ID: 21314441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.
    Levy D; Hwang SJ; Kayalar A; Benjamin EJ; Vasan RS; Parise H; Larson MG; Wang TJ; Selhub J; Jacques PF; Vita JA; Keyes MJ; Mitchell GF
    Circulation; 2007 Jun; 115(24):3079-85. PubMed ID: 17533184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between aortic augmentation index and cardiovascular risk factors in a large unselected population.
    Janner JH; Godtfredsen NS; Ladelund S; Vestbo J; Prescott E
    J Hum Hypertens; 2012 Aug; 26(8):476-84. PubMed ID: 21654851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry.
    Zahner GJ; Gruendl MA; Spaulding KA; Schaller MS; Hills NK; Gasper WJ; Grenon SM
    J Vasc Surg; 2017 Nov; 66(5):1518-1526. PubMed ID: 28756044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of arterial stiffness and wave reflection are associated with walking distance in patients with peripheral arterial disease.
    Brewer LC; Chai HS; Bailey KR; Kullo IJ
    Atherosclerosis; 2007 Apr; 191(2):384-90. PubMed ID: 16730015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification.
    Weber T; Auer J; Lamm G; O'Rourke MF; Eber B
    J Card Fail; 2007 Jun; 13(5):353-9. PubMed ID: 17602981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Fibulin-1 and Aortic Augmentation Index in Male Patients with Peripheral Arterial Disease.
    Paapstel K; Zilmer M; Eha J; Tootsi K; Piir A; Kals J
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):76-82. PubMed ID: 26507503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
    Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum N-terminal pro-B-type natriuretic peptide levels in patients with medial arterial calcification and poorly compressible leg arteries.
    Jouni H; Rodeheffer RJ; Kullo IJ
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):197-202. PubMed ID: 20947817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of endovascular lower-limb revascularisation on the aortic augmentation index in patients with peripheral arterial disease.
    Jacomella V; Shenoy A; Mosimann K; Kohler MK; Amann-Vesti B; Husmann M
    Eur J Vasc Endovasc Surg; 2013 May; 45(5):497-501. PubMed ID: 23453515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
    Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
    J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oscillometry and applanation tonometry measurements in older individuals with elevated levels of arterial stiffness.
    van Dijk SC; Enneman AW; Swart KM; van Schoor NM; Uitterlinden AG; Smulders YM; van den Meiracker AH; van der Velde N; Mattace-Raso FU
    Blood Press Monit; 2013 Dec; 18(6):332-8. PubMed ID: 24192847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients.
    Georgianos PI; Sarafidis PA; Malindretos P; Nikolaidis P; Lasaridis AN
    Am J Nephrol; 2011; 34(5):407-14. PubMed ID: 21934301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.